Core Viewpoint - Marex Group plc has faced a significant decline in share price following a critical short report alleging a multi-year accounting scheme involving misleading financial practices [1][4]. Group 1: Investigation and Allegations - Hagens Berman, a national shareholders rights firm, has initiated an investigation into Marex for potential violations of securities laws, urging affected investors to report their losses [2][5]. - The investigation focuses on the accuracy of Marex's financial statements and the adequacy of its disclosure controls [3][5]. - NINGI Research's report claims that Marex engaged in a complex accounting scheme using off-balance sheet entities and fictitious transactions to hide losses and inflate profits [4][7]. Group 2: Financial Manipulation Claims - The report alleges that Marex utilized an opaque fund structure in Luxembourg to manipulate earnings and conceal risk [7]. - It was revealed that Marex created an undisclosed off-balance sheet entity, the 'Marex Fund', which holds over $930 million in derivatives, with Marex as the sole counterparty, excluded from risk models [7]. - The report also criticizes Marex's operating cash flow claims, stating that after adjusting for reported debt, the cash flow was negative approximately $150 million in 2024 and negative about $258 million in 2023 [7].